Patients with Inherited Metabolic Disorders (IMD) transplanted with MGTA-456, a CD34+ Expanded Cell Therapy Product, Show Rapid Engraftment in Preliminary Phase 2 Trial Results (P4... von Orchard, Paul A., Raffel, Glen D., Condon, Carolyn E.H., Monaghan, Catherine A., Braun, Jennifer A., Shanley, Ryan, Lund, Troy C., Gupta, Ashish, Boitano, Anthony E., Cooke, Michael P., Davis, John C., Wagner, John E.

Volltext

Preliminary results demonstrate engraftment with minimal neutropenia with MGTA-456, a CD34+expanded cord blood (CB) product in patients transplanted for inherited metabolic disorde... von Orchard, Paul J., Raffel, Glen D., Condon, Carolyn E.H., Monaghan, Catherine A., Braun, Jennifer A., Shanley, Ryan, Lund, Troy C., Gupta, Ashish, Boitano, Anthony E., Cooke, Michael, Davis, Davis C., Wagner, John E.

Volltext

Preliminary results demonstrate engraftment with minimal neutropenia with MGTA-456, a CD34expanded cord blood (CB) product in patients transplanted for inherited metabolic disorder... von Orchard, Paul J., Raffel, Glen D., Condon, Carolyn E.H., Monaghan, Catherine A., Braun, Jennifer A., Shanley, Ryan, Lund, Troy C., Gupta, Ashish, Boitano, Anthony E., Cooke, Michael, Davis, Davis C., Wagner, John E.

Volltext

Mgta-456 Cell Therapy in Inherited Metabolic Disease (IMD) Yields Rapid and Durable Long-Term Improvement of Disease-Specific Outcomes in a Phase 2 Trial von Orchard, Paul J., Raffel, Glen D., Condon, Carolyn E.H., Braun, Jennifer A., Shanley, Ryan, Lund, Troy C., Gupta, Ashish, Boitano, Anthony E., Cooke, Michael P., Davis, John C., Wagner, John E.

Volltext